Scientific article
Open access

Transcription–replication conflicts underlie sensitivity to PARP inhibitors

Published inNature, vol. 628, no. 8007, p. 433-441
Publication date2024-03-20
First online date2024-03-20

An important advance in cancer therapy has been the development of poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of homologous recombination (HR)-deficient cancers 1–6 . PARP inhibitors trap PARPs on DNA. The trapped PARPs are thought to block replisome progression, leading to formation of DNA double-strand breaks that require HR for repair 7 . Here we show that PARP1 functions together with TIMELESS and TIPIN to protect the replisome in early S phase from transcription–replication conflicts. Furthermore, the synthetic lethality of PARP inhibitors with HR deficiency is due to an inability to repair DNA damage caused by transcription–replication conflicts, rather than by trapped PARPs. Along these lines, inhibiting transcription elongation in early S phase rendered HR-deficient cells resistant to PARP inhibitors and depleting PARP1 by small-interfering RNA was synthetic lethal with HR deficiency. Thus, inhibiting PARP1 enzymatic activity may suffice for treatment efficacy in HR-deficient settings.

Citation (ISO format)
PETROPOULOS, Michalis et al. Transcription–replication conflicts underlie sensitivity to PARP inhibitors. In: Nature, 2024, vol. 628, n° 8007, p. 433–441. doi: 10.1038/s41586-024-07217-2
Main files (1)
Article (Published version)
ISSN of the journal0028-0836

Technical informations

Creation05/13/2024 12:40:43 PM
First validation05/22/2024 1:47:58 PM
Update time05/22/2024 1:47:58 PM
Status update05/22/2024 1:47:58 PM
Last indexation05/22/2024 1:48:19 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack